These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice. Itagaki H, Shimizu K, Morikawa S, Ogawa K, Ezaki T. Int J Clin Exp Pathol; 2013; 6(12):2683-96. PubMed ID: 24294355 [Abstract] [Full Text] [Related]
3. The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse. Takano K, Kaneda M, Aoki Y, Fujita N, Chiba S, Michihara S, Han LK, Takahashi R. J Nat Med; 2024 Jun; 78(3):514-524. PubMed ID: 38498120 [Abstract] [Full Text] [Related]
4. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice. Susutlertpanya W, Wakuda H, Otani N, Kuramoto T, Li L, Kuranari M, Sekiguchi A, Kudo H, Uchida T, Imai H, Uemura N. Life Sci; 2019 Jul 01; 228():251-257. PubMed ID: 31078545 [Abstract] [Full Text] [Related]
5. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. Wei G, An P, Vaid KA, Nasser I, Huang P, Tan L, Zhao S, Schuppan D, Popov YV. Am J Physiol Gastrointest Liver Physiol; 2020 Jan 01; 318(1):G174-G188. PubMed ID: 31630534 [Abstract] [Full Text] [Related]
6. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet. Ikawa-Yoshida A, Matsuo S, Kato A, Ohmori Y, Higashida A, Kaneko E, Matsumoto M. Int J Exp Pathol; 2017 Aug 01; 98(4):221-233. PubMed ID: 28895242 [Abstract] [Full Text] [Related]
7. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice. Takatani N, Kono Y, Beppu F, Okamatsu-Ogura Y, Yamano Y, Miyashita K, Hosokawa M. Biochem Biophys Res Commun; 2020 Jul 23; 528(2):305-310. PubMed ID: 32475638 [Abstract] [Full Text] [Related]
8. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model. Hayashida M, Hashimoto K, Ishikawa T, Miyamoto Y. Int J Exp Pathol; 2019 Apr 23; 100(2):72-82. PubMed ID: 30887659 [Abstract] [Full Text] [Related]
9. Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis. Suga T, Yamaguchi H, Ogura J, Shoji S, Maekawa M, Mano N. Toxicol Appl Pharmacol; 2019 Sep 15; 379():114664. PubMed ID: 31306673 [Abstract] [Full Text] [Related]
10. Nonobese mice with nonalcoholic steatohepatitis fed on a choline-deficient, l-amino acid-defined, high-fat diet exhibit alterations in signaling pathways. Suzuki-Kemuriyama N, Abe A, Nakane S, Uno K, Ogawa S, Watanabe A, Sano R, Yuki M, Miyajima K, Nakae D. FEBS Open Bio; 2021 Nov 15; 11(11):2950-2965. PubMed ID: 34390210 [Abstract] [Full Text] [Related]
11. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH). Hartimath SV, Boominathan R, Soh V, Cheng P, Deng X, Chong YC, Yong FF, Tan PW, Han W, Robins EG, Goggi JL. Contrast Media Mol Imaging; 2019 Nov 15; 2019():6298128. PubMed ID: 31866798 [Abstract] [Full Text] [Related]
12. A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet. Suzuki-Kemuriyama N, Abe A, Uno K, Ogawa S, Watanabe A, Sano R, Yuki M, Miyajima K, Nakae D. Lipids Health Dis; 2020 Dec 14; 19(1):251. PubMed ID: 33317575 [Abstract] [Full Text] [Related]
13. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet. Alshawsh MA, Alsalahi A, Alshehade SA, Saghir SAM, Ahmeda AF, Al Zarzour RH, Mahmoud AM. Molecules; 2022 Jan 27; 27(3):. PubMed ID: 35164140 [Abstract] [Full Text] [Related]
14. Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease. Toita R, Kang JH. Toxicol Lett; 2020 Oct 10; 332():1-6. PubMed ID: 32579995 [Abstract] [Full Text] [Related]
15. Time-restricted feeding has a limited effect on hepatic lipid accumulation, inflammation and fibrosis in a choline-deficient high-fat diet-induced murine NASH model. Sato T, Oishi K. PLoS One; 2024 Oct 10; 19(1):e0296950. PubMed ID: 38285666 [Abstract] [Full Text] [Related]
16. Nicotinic alpha-7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non-alcoholic steatohepatitis. Kimura K, Inaba Y, Watanabe H, Matsukawa T, Matsumoto M, Inoue H. J Diabetes Investig; 2019 May 10; 10(3):659-666. PubMed ID: 30369082 [Abstract] [Full Text] [Related]
17. Effects of Caffeine and Chlorogenic Acid on Nonalcoholic Steatohepatitis in Mice Induced by Choline-Deficient, L-Amino Acid-Defined, High-Fat Diet. Dungubat E, Watabe S, Togashi-Kumagai A, Watanabe M, Kobayashi Y, Harada N, Yamaji R, Fukusato T, Lodon G, Sevjid B, Takahashi Y. Nutrients; 2020 Dec 18; 12(12):. PubMed ID: 33353230 [Abstract] [Full Text] [Related]
18. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM. Hepatology; 2009 Nov 18; 50(5):1421-30. PubMed ID: 19676126 [Abstract] [Full Text] [Related]
19. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis. Wang Q, Zhou H, Bu Q, Wei S, Li L, Zhou J, Zhou S, Su W, Liu M, Liu Z, Wang M, Lu L. J Hepatol; 2022 Aug 18; 77(2):312-325. PubMed ID: 35292349 [Abstract] [Full Text] [Related]
20. Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice. Chiba T, Suzuki S, Sato Y, Itoh T, Umegaki K. PLoS One; 2016 Aug 18; 11(10):e0164191. PubMed ID: 27723801 [Abstract] [Full Text] [Related] Page: [Next] [New Search]